- Non small cell lung cancer
- Non small cell lung - Adjuvant/neoadjuvant
- Non small cell lung - Advanced/metastatic
- EGFR L858R/exon 19 (First line,Subsequent)
- EGFR exon 20 (First line,Subsequent)
- ALK (First line,Subsequent)
- KRAS G12C (First line,Subsequent)
- BRAF (Subsequent)
- HER2 (First line,Subsequent)
- MET exon 14 skipping or amplification (First line,Subsequent)
- ROS1 (Subsequent)
- RET (Subsequent)
- Driverless, PD-L1-positive (First line, maintenance,Subsequent)
- Driverless (First line, maintenance,Subsequent)
- Small cell lung - Limited stage
- Small cell lung - Extensive stage
- Mesothelioma - Advanced/metastatic
Sarcoma, Endocrine, and Rare Cancers
⚠ The Haematology section is pending further clinical review in this beta version of ARTICANZ.
⚠ The Paediatric section is currently not fully curated or verified in this beta version of ARTICANZ. Information is incomplete.
⚠ The Radiation oncology section is currently not fully curated or verified in this beta version of ARTICANZ. Information is incomplete.